Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18493310 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine
Condition: Influenza
Intervention: Biological: VAX125

Indicates status has not been verified in more than two years